> top > docs > PMC:7195088 > spans > 39979-48269 > annotations

PMC:7195088 / 39979-48269 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1203 3618-3621 Gene denotes AST Gene:26503
1204 3203-3211 Species denotes patients Tax:9606
1205 3741-3749 Species denotes patients Tax:9606
1206 3924-3950 Species denotes Mycobacterium tuberculosis Tax:1773
1207 4150-4158 Species denotes patients Tax:9606
1208 2720-2733 Chemical denotes triglycerides MESH:D014280
1209 3997-4008 Chemical denotes tocilizumab MESH:C502936
1210 2666-2699 Disease denotes ritonavir • Hypercholesterolaemia MESH:C564286
1211 2788-2797 Disease denotes Diarrhoea MESH:D003967
1212 2881-2887 Disease denotes Nausea MESH:D009325
1213 2898-2931 Disease denotes Upper respiratory tract infection MESH:D012141
1214 2940-2954 Disease denotes Abdominal pain MESH:D015746
1215 2983-2990 Disease denotes Fatigue MESH:D005221
1216 3045-3053 Disease denotes Headache MESH:D006261
1217 3063-3072 Disease denotes Skin rash MESH:D005076
1218 3081-3092 Disease denotes Neutropenia MESH:D009503
1219 3113-3120 Disease denotes Anxiety MESH:D001007
1220 3128-3136 Disease denotes Insomnia MESH:D007319
1221 3176-3187 Disease denotes Retinopathy MESH:D012164
1222 3270-3294 Disease denotes Stevens-Johnson syndrome MESH:D013262
1223 3296-3310 Disease denotes abdominal pain MESH:D015746
1224 3312-3321 Disease denotes diarrhoea MESH:D003967
1225 3323-3329 Disease denotes nausea MESH:D009325
1226 3331-3339 Disease denotes vomiting MESH:D014839
1227 3341-3356 Disease denotes agranulocytosis MESH:D000380
1228 3358-3368 Disease denotes leukopenia MESH:D007970
1229 3370-3386 Disease denotes thrombocytopenia MESH:D013921
1230 3443-3451 Disease denotes myopathy MESH:D009135
1231 3453-3465 Disease denotes bronchospasm MESH:D001986
1232 3701-3712 Disease denotes Neutropenia MESH:D009503
1233 3753-3761 Disease denotes Headache MESH:D006261
1234 3771-3783 Disease denotes Hypertension MESH:D006973
1235 3793-3802 Disease denotes Dizziness MESH:D004244
1236 3810-3824 Disease denotes Hypothyroidism MESH:D007037
1237 3833-3847 Disease denotes Abdominal pain MESH:D015746
1238 3870-3884 Disease denotes gastric ulcers MESH:D013276
1239 3892-3902 Disease denotes Infections MESH:D007239
1240 3910-3922 Disease denotes Pneumocystis MESH:D011020
1241 4225-4233 Disease denotes Headache MESH:D006261
1242 4238-4246 Disease denotes vomiting MESH:D014839
1243 4258-4268 Disease denotes Arthralgia MESH:D018771
1244 4280-4285 Disease denotes Fever MESH:D005334
1245 4297-4318 Disease denotes Haematologic disorder MESH:D006402
1246 4329-4341 Disease denotes eosinophilia MESH:D004802
1247 4343-4353 Disease denotes leukopenia MESH:D007970
1248 4392-4398 Disease denotes Nausea MESH:D009325
1249 4403-4412 Disease denotes diarrhoea MESH:D003967
1251 2618-2626 Disease denotes COVID-19 MESH:C000657245
1253 4519-4527 Disease denotes COVID-19 MESH:C000657245
1257 4587-4611 Gene denotes alanine aminotransferase Gene:2875
1258 4613-4616 Gene denotes AST Gene:26503
1259 4656-4680 Disease denotes coronavirus disease 2019 MESH:C000657245
1264 4932-4942 Disease denotes infections MESH:D007239
1265 4952-4962 Disease denotes cellulitis MESH:D002481
1266 4964-4973 Disease denotes pneumonia MESH:D011014
1267 4979-5004 Disease denotes bone and joint infections MESH:D007239
1294 122-132 Species denotes SARS-CoV-2 Tax:2697049
1295 142-155 Species denotes coronaviruses Tax:11118
1296 214-225 Species denotes coronavirus Tax:11118
1297 399-407 Species denotes patients Tax:9606
1298 521-529 Species denotes SARS-CoV Tax:694009
1299 573-582 Species denotes MERS)-CoV Tax:1335626
1300 741-749 Species denotes patients Tax:9606
1301 1048-1056 Species denotes patients Tax:9606
1302 2079-2087 Species denotes patients Tax:9606
1303 2219-2227 Species denotes patients Tax:9606
1304 335-344 Chemical denotes Lopinavir MESH:D061466
1305 442-451 Chemical denotes ritonavir MESH:D019438
1306 643-662 Chemical denotes lopinavir/ritonavir MESH:C558899
1307 664-671 Chemical denotes LPV/RTV MESH:C558899
1308 1090-1097 Chemical denotes LPV/RTV MESH:C558899
1309 1472-1479 Chemical denotes LPV/RTV MESH:C558899
1310 1703-1710 Chemical denotes LPV/RTV MESH:C558899
1311 1797-1804 Chemical denotes LPV/RTV MESH:C558899
1312 2007-2014 Chemical denotes LPV/RTV MESH:C558899
1313 2332-2350 Chemical denotes hydroxychloroquine MESH:D006886
1314 539-571 Disease denotes Middle East respiratory syndrome MESH:D018352
1315 732-740 Disease denotes COVID-19 MESH:C000657245
1316 1027-1032 Disease denotes death MESH:D003643
1317 1402-1411 Disease denotes mortality MESH:D003643
1318 1442-1448 Disease denotes deaths MESH:D003643
1319 2070-2078 Disease denotes COVID-19 MESH:C000657245
1329 5095-5100 Species denotes Ebola Tax:1570291
1330 5139-5152 Species denotes coronaviruses Tax:11118
1331 5154-5164 Species denotes SARS-CoV-2 Tax:2697049
1332 5166-5174 Species denotes SARS-CoV Tax:694009
1333 5181-5189 Species denotes MERS-CoV Tax:1335626
1334 5326-5334 Species denotes patients Tax:9606
1335 5006-5016 Chemical denotes Remdesivir MESH:C000606551
1336 5464-5474 Chemical denotes remdesivir MESH:C000606551
1337 5317-5325 Disease denotes COVID-19 MESH:C000657245
1357 5628-5641 Gene denotes neuraminidase Gene:4758
1358 5738-5746 Species denotes patients Tax:9606
1359 5854-5862 Species denotes SARS-CoV Tax:694009
1360 5936-5944 Species denotes patients Tax:9606
1361 6171-6179 Species denotes patients Tax:9606
1362 5671-5680 Species denotes influenza Tax:11520
1363 6052-6061 Species denotes influenza Tax:11520
1364 6235-6244 Species denotes influenza Tax:11520
1365 5598-5609 Chemical denotes Oseltamivir MESH:D053139
1366 5614-5623 Chemical denotes zanamivir MESH:D053243
1367 5791-5802 Chemical denotes oseltamivir MESH:D053139
1368 5807-5816 Chemical denotes zanamivir MESH:D053243
1369 5968-5979 Chemical denotes oseltamivir MESH:D053139
1370 5729-5737 Disease denotes COVID-19 MESH:C000657245
1371 5921-5935 Disease denotes critically ill MESH:D016638
1372 5950-5958 Disease denotes COVID-19 MESH:C000657245
1373 6020-6029 Disease denotes infection MESH:D007239
1374 6034-6045 Disease denotes coinfection MESH:D060085
1375 6162-6170 Disease denotes COVID-19 MESH:C000657245
1395 6335-6343 Species denotes patients Tax:9606
1396 6915-6923 Species denotes patients Tax:9606
1397 6969-6977 Species denotes patients Tax:9606
1398 7051-7059 Species denotes patients Tax:9606
1399 7365-7375 Species denotes SARS-CoV-2 Tax:2697049
1400 6413-6422 Species denotes influenza Tax:11520
1401 6458-6467 Species denotes influenza Tax:11520
1402 7314-7322 Species denotes patients Tax:9606
1403 6437-6447 Chemical denotes umifenovir MESH:C086979
1404 6668-6679 Chemical denotes favipiravir MESH:C462182
1405 6937-6948 Chemical denotes favipiravir MESH:C462182
1406 6988-6998 Chemical denotes umifenovir MESH:C086979
1407 7070-7081 Chemical denotes favipiravir MESH:C462182
1408 6326-6334 Disease denotes COVID-19 MESH:C000657245
1409 6906-6914 Disease denotes COVID-19 MESH:C000657245
1410 6960-6968 Disease denotes COVID-19 MESH:C000657245
1411 7120-7129 Disease denotes mortality MESH:D003643
1412 7290-7304 Disease denotes critically ill MESH:D016638
1413 7305-7313 Disease denotes COVID-19 MESH:C000657245
1426 7613-7621 Species denotes patients Tax:9606
1427 7873-7881 Species denotes patients Tax:9606
1428 8280-8289 Species denotes influenza Tax:11520
1429 7593-7600 Chemical denotes LPV/RTV MESH:C558899
1430 7701-7710 Chemical denotes darunavir MESH:D000069454
1431 7811-7821 Chemical denotes remdesivir MESH:C000606551
1432 8041-8052 Chemical denotes favipiravir MESH:C462182
1433 8057-8067 Chemical denotes umifenovir MESH:C086979
1434 8183-8194 Chemical denotes Oseltamivir MESH:D053139
1435 8198-8207 Chemical denotes zanamivir MESH:D053243
1436 7604-7612 Disease denotes COVID-19 MESH:C000657245
1437 7864-7872 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T62 395-398 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T63 467-472 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T64 1480-1483 Body_part denotes arm http://purl.org/sig/ont/fma/fma24890
T65 2714-2719 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T66 2850-2855 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T67 2898-2921 Body_part denotes Upper respiratory tract http://purl.org/sig/ont/fma/fma45661
T68 3008-3013 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T69 3063-3067 Body_part denotes Skin http://purl.org/sig/ont/fma/fma7163
T70 3597-3602 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T71 3641-3644 Body_part denotes LDL http://purl.org/sig/ont/fma/fma63170
T72 3855-3866 Body_part denotes Oral mucosa http://purl.org/sig/ont/fma/fma59660
T73 3860-3866 Body_part denotes mucosa http://purl.org/sig/ont/fma/fma85355
T74 4111-4119 Body_part denotes Antibody http://purl.org/sig/ont/fma/fma62871
T75 4181-4189 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T76 4368-4376 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T77 4587-4594 Body_part denotes alanine http://purl.org/sig/ont/fma/fma82749
T78 4682-4685 Body_part denotes LDL http://purl.org/sig/ont/fma/fma63170
T79 4687-4710 Body_part denotes low-density lipoprotein http://purl.org/sig/ont/fma/fma63170
T80 4714-4719 Body_part denotes Serum http://purl.org/sig/ont/fma/fma63083
T81 4988-4993 Body_part denotes joint http://purl.org/sig/ont/fma/fma7490
T82 5039-5049 Body_part denotes nucleotide http://purl.org/sig/ont/fma/fma82740
T83 6364-6367 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T84 6378-6381 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T33 467-472 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T34 977-982 Body_part denotes scale http://purl.obolibrary.org/obo/UBERON_0002542
T35 1480-1483 Body_part denotes arm http://purl.obolibrary.org/obo/UBERON_0001460
T36 2714-2719 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T37 2850-2855 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T38 2898-2921 Body_part denotes Upper respiratory tract http://purl.obolibrary.org/obo/UBERON_0001557
T39 2904-2921 Body_part denotes respiratory tract http://purl.obolibrary.org/obo/UBERON_0000065
T40 3008-3013 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T41 3063-3067 Body_part denotes Skin http://purl.obolibrary.org/obo/UBERON_0000014
T42 3597-3602 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T43 3860-3866 Body_part denotes mucosa http://purl.obolibrary.org/obo/UBERON_0000344
T44 4714-4719 Body_part denotes Serum http://purl.obolibrary.org/obo/UBERON_0001977

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T45 2704-2733 Phenotype denotes increased serum triglycerides http://purl.obolibrary.org/obo/HP_0002155
T46 2788-2797 Phenotype denotes Diarrhoea http://purl.obolibrary.org/obo/HP_0002014
T47 2881-2887 Phenotype denotes Nausea http://purl.obolibrary.org/obo/HP_0002018
T48 2898-2931 Phenotype denotes Upper respiratory tract infection http://purl.obolibrary.org/obo/HP_0002788
T49 2940-2954 Phenotype denotes Abdominal pain http://purl.obolibrary.org/obo/HP_0002027
T50 2965-2973 Phenotype denotes Vomiting http://purl.obolibrary.org/obo/HP_0002013
T51 2983-2990 Phenotype denotes Fatigue http://purl.obolibrary.org/obo/HP_0012378
T52 3045-3053 Phenotype denotes Headache http://purl.obolibrary.org/obo/HP_0002315
T53 3063-3072 Phenotype denotes Skin rash http://purl.obolibrary.org/obo/HP_0000988
T54 3081-3092 Phenotype denotes Neutropenia http://purl.obolibrary.org/obo/HP_0001875
T55 3113-3120 Phenotype denotes Anxiety http://purl.obolibrary.org/obo/HP_0000739
T56 3128-3136 Phenotype denotes Insomnia http://purl.obolibrary.org/obo/HP_0100785
T57 3176-3187 Phenotype denotes Retinopathy http://purl.obolibrary.org/obo/HP_0000488
T58 3296-3310 Phenotype denotes abdominal pain http://purl.obolibrary.org/obo/HP_0002027
T59 3312-3321 Phenotype denotes diarrhoea http://purl.obolibrary.org/obo/HP_0002014
T60 3323-3339 Phenotype denotes nausea, vomiting http://purl.obolibrary.org/obo/HP_0002017
T61 3341-3356 Phenotype denotes agranulocytosis http://purl.obolibrary.org/obo/HP_0012234
T62 3358-3368 Phenotype denotes leukopenia http://purl.obolibrary.org/obo/HP_0001882
T63 3370-3386 Phenotype denotes thrombocytopenia http://purl.obolibrary.org/obo/HP_0001873
T64 3421-3434 Phenotype denotes acute hepatic http://purl.obolibrary.org/obo/HP_0200119
T65 3443-3451 Phenotype denotes myopathy http://purl.obolibrary.org/obo/HP_0003198
T66 3453-3465 Phenotype denotes bronchospasm http://purl.obolibrary.org/obo/HP_0025428
T67 3476-3497 Phenotype denotes prolonged QT interval http://purl.obolibrary.org/obo/HP_0001657
T68 3631-3656 Phenotype denotes Increased LDL cholesterol http://purl.obolibrary.org/obo/HP_0003141
T69 3701-3712 Phenotype denotes Neutropenia http://purl.obolibrary.org/obo/HP_0001875
T70 3753-3761 Phenotype denotes Headache http://purl.obolibrary.org/obo/HP_0002315
T71 3771-3783 Phenotype denotes Hypertension http://purl.obolibrary.org/obo/HP_0000822
T72 3793-3802 Phenotype denotes Dizziness http://purl.obolibrary.org/obo/HP_0002321
T73 3810-3824 Phenotype denotes Hypothyroidism http://purl.obolibrary.org/obo/HP_0000821
T74 3833-3847 Phenotype denotes Abdominal pain http://purl.obolibrary.org/obo/HP_0002027
T75 3870-3884 Phenotype denotes gastric ulcers http://purl.obolibrary.org/obo/HP_0002592
T76 4225-4233 Phenotype denotes Headache http://purl.obolibrary.org/obo/HP_0002315
T77 4238-4246 Phenotype denotes vomiting http://purl.obolibrary.org/obo/HP_0002013
T78 4258-4268 Phenotype denotes Arthralgia http://purl.obolibrary.org/obo/HP_0002829
T79 4280-4285 Phenotype denotes Fever http://purl.obolibrary.org/obo/HP_0001945
T80 4329-4341 Phenotype denotes eosinophilia http://purl.obolibrary.org/obo/HP_0001880
T81 4343-4353 Phenotype denotes leukopenia http://purl.obolibrary.org/obo/HP_0001882
T82 4392-4398 Phenotype denotes Nausea http://purl.obolibrary.org/obo/HP_0002018
T83 4403-4412 Phenotype denotes diarrhoea http://purl.obolibrary.org/obo/HP_0002014
T84 4952-4962 Phenotype denotes cellulitis http://purl.obolibrary.org/obo/HP_0100658
T85 4964-4973 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T205 122-130 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T206 521-529 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T207 732-740 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T208 2070-2078 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T209 2618-2626 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T210 2788-2797 Disease denotes Diarrhoea http://purl.obolibrary.org/obo/MONDO_0001673
T211 2904-2931 Disease denotes respiratory tract infection http://purl.obolibrary.org/obo/MONDO_0024355
T212 2922-2931 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T213 3063-3072 Disease denotes Skin rash http://purl.obolibrary.org/obo/MONDO_0006547
T214 3081-3092 Disease denotes Neutropenia http://purl.obolibrary.org/obo/MONDO_0001475
T215 3113-3120 Disease denotes Anxiety http://purl.obolibrary.org/obo/MONDO_0005618|http://purl.obolibrary.org/obo/MONDO_0011918
T217 3128-3136 Disease denotes Insomnia http://purl.obolibrary.org/obo/MONDO_0013600
T218 3176-3187 Disease denotes Retinopathy http://purl.obolibrary.org/obo/MONDO_0005283
T219 3270-3294 Disease denotes Stevens-Johnson syndrome http://purl.obolibrary.org/obo/MONDO_0018229
T220 3278-3294 Disease denotes Johnson syndrome http://purl.obolibrary.org/obo/MONDO_0019419
T221 3312-3321 Disease denotes diarrhoea http://purl.obolibrary.org/obo/MONDO_0001673
T222 3341-3356 Disease denotes agranulocytosis http://purl.obolibrary.org/obo/MONDO_0001609
T223 3358-3368 Disease denotes leukopenia http://purl.obolibrary.org/obo/MONDO_0003785
T224 3370-3386 Disease denotes thrombocytopenia http://purl.obolibrary.org/obo/MONDO_0002049
T225 3443-3451 Disease denotes myopathy http://purl.obolibrary.org/obo/MONDO_0005336
T226 3453-3465 Disease denotes bronchospasm http://purl.obolibrary.org/obo/MONDO_0001358
T227 3701-3712 Disease denotes Neutropenia http://purl.obolibrary.org/obo/MONDO_0001475
T228 3771-3783 Disease denotes Hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T229 3810-3824 Disease denotes Hypothyroidism http://purl.obolibrary.org/obo/MONDO_0005420
T230 3870-3884 Disease denotes gastric ulcers http://purl.obolibrary.org/obo/MONDO_0001126
T231 3878-3884 Disease denotes ulcers http://purl.obolibrary.org/obo/MONDO_0043839
T232 3910-3922 Disease denotes Pneumocystis http://purl.obolibrary.org/obo/MONDO_0019121
T233 3938-3950 Disease denotes tuberculosis http://purl.obolibrary.org/obo/MONDO_0018076
T234 3955-3964 Disease denotes varicella http://purl.obolibrary.org/obo/MONDO_0005700
T235 3965-3971 Disease denotes zoster http://purl.obolibrary.org/obo/MONDO_0005609
T236 4329-4341 Disease denotes eosinophilia http://purl.obolibrary.org/obo/MONDO_0015691
T237 4343-4353 Disease denotes leukopenia http://purl.obolibrary.org/obo/MONDO_0003785
T238 4403-4412 Disease denotes diarrhoea http://purl.obolibrary.org/obo/MONDO_0001673
T239 4519-4527 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T240 4646-4654 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T241 4656-4680 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T242 4932-4942 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T243 4952-4962 Disease denotes cellulitis http://purl.obolibrary.org/obo/MONDO_0005230
T244 4964-4973 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T245 4994-5004 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T246 5095-5100 Disease denotes Ebola http://purl.obolibrary.org/obo/MONDO_0005737
T247 5154-5162 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T248 5166-5174 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T249 5317-5325 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T250 5671-5680 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T251 5729-5737 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T252 5854-5862 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T253 5950-5958 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T254 6020-6029 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T255 6052-6061 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T256 6162-6170 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T257 6235-6244 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T258 6326-6334 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T259 6413-6422 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T260 6458-6467 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T261 6906-6914 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T262 6960-6968 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T263 7305-7313 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T264 7365-7373 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T265 7604-7612 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T266 7864-7872 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T267 8280-8289 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T223 105-113 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T224 348-349 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T225 504-512 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T226 608-614 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T227 761-766 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T228 781-783 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T229 877-878 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T230 952-953 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T231 1118-1122 http://www.ebi.ac.uk/efo/EFO_0001410 denotes arms
T232 1422-1423 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T233 1480-1483 http://www.ebi.ac.uk/efo/EFO_0001410 denotes arm
T234 1535-1539 http://www.ebi.ac.uk/efo/EFO_0001410 denotes arms
T235 1654-1655 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T236 1753-1758 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T237 2371-2372 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T238 2575-2580 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T239 2867-2870 http://purl.obolibrary.org/obo/CLO_0001302 denotes 3/4
T240 2874-2876 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T241 2958-2960 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T242 2975-2978 http://purl.obolibrary.org/obo/CLO_0050509 denotes 2–7
T243 3063-3067 http://purl.obolibrary.org/obo/UBERON_0000014 denotes Skin
T244 3063-3067 http://purl.obolibrary.org/obo/UBERON_0001003 denotes Skin
T245 3063-3067 http://purl.obolibrary.org/obo/UBERON_0002097 denotes Skin
T246 3063-3067 http://purl.obolibrary.org/obo/UBERON_0002199 denotes Skin
T247 3063-3067 http://www.ebi.ac.uk/efo/EFO_0000962 denotes Skin
T248 3100-3103 http://purl.obolibrary.org/obo/CLO_0001302 denotes 3/4
T249 3212-3213 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T250 3414-3419 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T251 3609-3611 http://purl.obolibrary.org/obo/CLO_0001313 denotes 36
T252 3624-3626 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T253 3723-3726 http://purl.obolibrary.org/obo/CLO_0050509 denotes 2–7
T254 3860-3866 http://purl.obolibrary.org/obo/UBERON_0000344 denotes mucosa
T255 4031-4034 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T256 4104-4106 http://purl.obolibrary.org/obo/CLO_0054055 denotes 71
T257 4452-4457 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T258 4712-4713 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T259 4853-4854 http://purl.obolibrary.org/obo/CLO_0001021 denotes b
T260 4979-4983 http://purl.obolibrary.org/obo/UBERON_0002481 denotes bone
T261 4988-4993 http://purl.obolibrary.org/obo/UBERON_0000982 denotes joint
T262 4988-4993 http://purl.obolibrary.org/obo/UBERON_0004905 denotes joint
T263 5122-5130 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T264 5217-5223 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T265 5702-5708 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T266 5779-5787 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T267 5817-5820 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T268 5875-5877 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T269 6423-6431 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T270 6468-6476 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T271 6811-6815 http://purl.obolibrary.org/obo/CLO_0008416 denotes peer
T272 6811-6815 http://purl.obolibrary.org/obo/CLO_0050081 denotes peer
T273 6879-6880 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T274 7348-7356 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T275 7385-7388 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T276 7572-7577 http://purl.obolibrary.org/obo/CLO_0007225 denotes label

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T504 19-35 Chemical denotes antiviral agents http://purl.obolibrary.org/obo/CHEBI_22587
T505 61-77 Chemical denotes antiviral agents http://purl.obolibrary.org/obo/CHEBI_22587
T506 193-209 Chemical denotes antiviral agents http://purl.obolibrary.org/obo/CHEBI_22587
T507 335-344 Chemical denotes Lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T508 350-368 Chemical denotes protease inhibitor http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258
T510 359-368 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T511 442-451 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T512 643-662 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T513 643-652 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T514 653-662 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T515 761-766 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T516 1753-1758 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T517 2028-2047 Chemical denotes protease inhibitors http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258
T519 2037-2047 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T520 2056-2065 Chemical denotes darunavir http://purl.obolibrary.org/obo/CHEBI_367163
T521 2274-2278 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T522 2295-2305 Chemical denotes antivirals http://purl.obolibrary.org/obo/CHEBI_22587
T523 2317-2322 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T524 2332-2350 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T525 2528-2551 Chemical denotes anti-inflammatory drugs http://purl.obolibrary.org/obo/CHEBI_35472
T526 2546-2551 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T527 2575-2580 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T528 2656-2665 Chemical denotes Lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T529 2666-2675 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T530 2720-2733 Chemical denotes triglycerides http://purl.obolibrary.org/obo/CHEBI_17855
T531 2756-2764 Chemical denotes glutamyl http://purl.obolibrary.org/obo/CHEBI_32483
T532 3143-3154 Chemical denotes Chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T533 3155-3173 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T534 3560-3572 Chemical denotes azithromycin http://purl.obolibrary.org/obo/CHEBI_2955
T535 3618-3621 Chemical denotes AST http://purl.obolibrary.org/obo/CHEBI_76649
T536 3641-3656 Chemical denotes LDL cholesterol http://purl.obolibrary.org/obo/CHEBI_47774
T537 3641-3644 Chemical denotes LDL http://purl.obolibrary.org/obo/CHEBI_39026
T538 3645-3656 Chemical denotes cholesterol http://purl.obolibrary.org/obo/CHEBI_16113
T539 3997-4008 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T540 4452-4457 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T541 4458-4463 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T542 4587-4594 Chemical denotes alanine http://purl.obolibrary.org/obo/CHEBI_16449
T543 4613-4616 Chemical denotes AST http://purl.obolibrary.org/obo/CHEBI_76649
T544 4618-4627 Chemical denotes aspartate http://purl.obolibrary.org/obo/CHEBI_132943|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_72314
T547 4682-4685 Chemical denotes LDL http://purl.obolibrary.org/obo/CHEBI_39026
T548 4687-4710 Chemical denotes low-density lipoprotein http://purl.obolibrary.org/obo/CHEBI_39026
T549 4699-4710 Chemical denotes lipoprotein http://purl.obolibrary.org/obo/CHEBI_6495
T550 5039-5049 Chemical denotes nucleotide http://purl.obolibrary.org/obo/CHEBI_36976
T551 5448-5452 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T552 5464-5474 Chemical denotes remdesivir http://purl.obolibrary.org/obo/CHEBI_145994
T553 5598-5609 Chemical denotes Oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T554 5614-5623 Chemical denotes zanamivir http://purl.obolibrary.org/obo/CHEBI_50663
T555 5628-5652 Chemical denotes neuraminidase inhibitors http://purl.obolibrary.org/obo/CHEBI_52425
T556 5642-5652 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T557 5791-5802 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T558 5807-5816 Chemical denotes zanamivir http://purl.obolibrary.org/obo/CHEBI_50663
T559 5968-5979 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T560 6252-6268 Chemical denotes antiviral agents http://purl.obolibrary.org/obo/CHEBI_22587
T561 6348-6359 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T562 6378-6402 Chemical denotes RNA polymerase inhibitor http://purl.obolibrary.org/obo/CHEBI_37416
T563 6393-6402 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T564 6437-6447 Chemical denotes umifenovir http://purl.obolibrary.org/obo/CHEBI_134730
T565 6484-6493 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T566 6668-6679 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T567 6937-6948 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T568 6988-6998 Chemical denotes umifenovir http://purl.obolibrary.org/obo/CHEBI_134730
T569 7070-7081 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T570 7338-7347 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T571 7416-7426 Chemical denotes ivermectin http://purl.obolibrary.org/obo/CHEBI_6078
T572 7572-7577 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T573 7675-7694 Chemical denotes protease inhibitors http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258
T575 7684-7694 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T576 7701-7710 Chemical denotes darunavir http://purl.obolibrary.org/obo/CHEBI_367163
T577 7811-7821 Chemical denotes remdesivir http://purl.obolibrary.org/obo/CHEBI_145994
T578 8041-8052 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T579 8057-8067 Chemical denotes umifenovir http://purl.obolibrary.org/obo/CHEBI_134730
T580 8183-8194 Chemical denotes Oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T581 8198-8207 Chemical denotes zanamivir http://purl.obolibrary.org/obo/CHEBI_50663

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T14 6468-6483 http://purl.obolibrary.org/obo/GO_0061025 denotes membrane fusion

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T302 0-52 Sentence denotes Question 2. should antiviral agents be administered?
T303 53-334 Sentence denotes Several antiviral agents have demonstrated in vitro activity against SARS-CoV-2 or other coronaviruses, but currently there are no approved antiviral agents for coronavirus-related diseases, and there are still no favourable efficacy results from RCT available at the present time.
T304 335-483 Sentence denotes Lopinavir is a protease inhibitor used for the treatment of HIV patients, administered in combination with ritonavir to improve its serum half-life.
T305 484-785 Sentence denotes On the basis of its activity against SARS-CoV-1 and/or Middle East respiratory syndrome (MERS)-CoV observed in in vitro and animal studies [[19], [20], [21]], lopinavir/ritonavir (LPV/RTV) was compared to supportive care alone for the treatment of COVID-19 patients in an open-label RCT in China [22].
T306 786-1034 Sentence denotes The primary time-to-event endpoint was clinical improvement from randomization (defined as a composite of discharge from the hospital or improvement of two points on a seven-category ordinal scale, ranging from no need of hospitalization to death).
T307 1035-1138 Sentence denotes Overall, 199 patients were enrolled (99 and 100 in the LPV/RTV and supportive care arms, respectively).
T308 1139-1336 Sentence denotes No differences were observed in the intent-to-treat population with regard to clinical improvement (hazard ratio 1.24 with standard of care as reference, 95% confidence interval (CI) 0.90 to 1.72).
T309 1337-1605 Sentence denotes In addition, no associations were observed with regard to 28-day mortality, although a smaller number of deaths were registered in the LPV/RTV arm (19.2% vs. 25.0% in investigational and comparator arms, respectively; percentage difference −5.8%, 95% CI −17.3 to 5.7).
T310 1606-2252 Sentence denotes Although some important considerations preclude a definite judgement on the possible efficacy of LPV/RTV (e.g. some major limitations are the open-label nature of the trial and the fact that LPV/RTV was initiated late with respect to the onset of symptoms; see question 7), especially in the case of early therapy initiation, the results of this RCT provide evidence currently discouraging the use of LPV/RTV (or of other protease inhibitors such as darunavir) in COVID-19 patients (also considering the potential side effects; Table 3 ), unless favourable results from other ongoing RCT in specific subgroups of patients are available (Table 2).
T311 2253-2467 Sentence denotes Furthermore, harmful drug interactions of antivirals with other drugs (such as hydroxychloroquine) cannot be excluded a priori because there are currently no large clinical data about the use of these combinations.
T312 2468-2635 Sentence denotes Table 3 Known adverse events of marketed anti-infective and anti-inflammatory drugs mostly provided as off-label treatments in the first phase of the COVID-19 pandemic
T313 2636-2655 Sentence denotes Drug Adverse events
T314 2656-2741 Sentence denotes Lopinavir/ritonavir • Hypercholesterolaemia and increased serum triglycerides (3–39%)
T315 2742-2785 Sentence denotes • Increased γ-glutamyl transferase (10–29%)
T316 2786-2837 Sentence denotes • Diarrhoea (7–28%; greater with once-daily dosing)
T317 2838-2871 Sentence denotes • Increased serum ALT (grade 3/4:
T318 2872-2878 Sentence denotes 1–11%)
T319 2879-2895 Sentence denotes • Nausea (5–16%)
T320 2896-2937 Sentence denotes • Upper respiratory tract infection (14%)
T321 2938-2962 Sentence denotes • Abdominal pain (1–11%)
T322 2963-2980 Sentence denotes • Vomiting (2–7%)
T323 2981-2995 Sentence denotes • Fatigue (8%)
T324 2996-3042 Sentence denotes • Increased serum amylase and/or lipase (3–8%)
T325 3043-3060 Sentence denotes • Headache (2–6%)
T326 3061-3078 Sentence denotes • Skin rash (≤5%)
T327 3079-3104 Sentence denotes • Neutropenia (grade 3/4:
T328 3105-3110 Sentence denotes 1–5%)
T329 3111-3125 Sentence denotes • Anxiety (4%)
T330 3126-3142 Sentence denotes • Insomnia (≤4%)
T331 3143-3213 Sentence denotes Chloroquine/hydroxychloroquine • Retinopathy (4% of treated patients)a
T332 3214-3465 Sentence denotes • Other adverse effects with unknown frequency included Stevens-Johnson syndrome, abdominal pain, diarrhoea, nausea, vomiting, agranulocytosis, leukopenia, thrombocytopenia, abnormal hepatic function tests, acute hepatic ailure, myopathy, bronchospasm
T333 3466-3572 Sentence denotes • Risk of prolonged QT interval, further increased when administered with fluoroquinolones or azithromycin
T334 3573-3628 Sentence denotes Tocilizumab • Increased serum ALT (≤36%) and AST (≤22%)
T335 3629-3664 Sentence denotes • Increased LDL cholesterol (9–10%)
T336 3665-3698 Sentence denotes • Injection site reaction (4–10%)
T337 3699-3722 Sentence denotes • Neutropenia (grade 3:
T338 3723-3750 Sentence denotes 2–7% of all adult patients)
T339 3751-3768 Sentence denotes • Headache (1–7%)
T340 3769-3790 Sentence denotes • Hypertension (1–6%)
T341 3791-3807 Sentence denotes • Dizziness (3%)
T342 3808-3830 Sentence denotes • Hypothyroidism (<2%)
T343 3831-3852 Sentence denotes • Abdominal pain (2%)
T344 3853-3889 Sentence denotes • Oral mucosa or gastric ulcers (2%)
T345 3890-4063 Sentence denotes • Infections due to Pneumocystis, Mycobacterium tuberculosis and varicella zoster have been reported after tocilizumab, but their prevalence has not been clearly established
T346 4064-4108 Sentence denotes Anakinra • Injection site reactionb (24–71%)
T347 4109-4222 Sentence denotes • Antibody development (up to 50% of the patients but no correlation of antibody development and adverse effects)
T348 4223-4255 Sentence denotes • Headache and vomiting (12–14%)
T349 4256-4277 Sentence denotes • Arthralgia (10–12%)
T350 4278-4294 Sentence denotes • Fever (10–12%)
T351 4295-4389 Sentence denotes • Haematologic disorder including eosinophilia, leukopenia and change in platelet count (2–9%)
T352 4390-4419 Sentence denotes • Nausea and diarrhoea (7–8%)
T353 4420-4447 Sentence denotes • Serious infectionc (2–3%)
T354 4448-4581 Sentence denotes Off-label drugs mostly provided in Italy during the first phase of the COVID-19 pandemic according to the authors' direct experience.
T355 4582-4711 Sentence denotes ALT, alanine aminotransferase; AST, aspartate aminotransferase; COVID-19, coronavirus disease 2019; LDL, low-density lipoprotein.
T356 4712-4852 Sentence denotes a Serum concentration dependent adverse effect; early changes are generally reversible but may progress despite discontinuation if advanced.
T357 4853-4921 Sentence denotes b Injection site reactions were considered serious in 2–3% of cases.
T358 4922-5005 Sentence denotes c Serious infections included cellulitis, pneumonia, and bone and joint infections.
T359 5006-5261 Sentence denotes Remdesivir is an investigational nucleotide analogue undergoing clinical development for Ebola and showing in vitro activity against coronaviruses (SARS-CoV-2, SARS-CoV-1 and MERS-CoV) and favourable effects in animal MERS models [[23], [24], [25], [26]].
T360 5262-5365 Sentence denotes Following these promising preclinical findings, RCT in COVID-19 patients have been initiated (Table 2).
T361 5366-5597 Sentence denotes However, pending their results, and considering the investigational nature of the drug, access to remdesivir outside RCT is currently provided only within strictly regulated and limited compassionate-use/expanded-access frameworks.
T362 5598-5757 Sentence denotes Oseltamivir and zanamivir are neuraminidase inhibitors used for treating influenza which are also being tested in RCT for treating COVID-19 patients (Table 2).
T363 5758-6067 Sentence denotes However, no apparent activity of oseltamivir and zanamivir has previously been observed against SARS-CoV-1 in vitro [27], and the fact that up to 76% of the first critically ill patients with COVID-19 received oseltamivir may also be related to the suspicion of infection (or coinfection) with influenza [28].
T364 6068-6245 Sentence denotes Overall, this information is currently insufficient for supporting the use of these agents in COVID-19 patients unless in the presence of suspected/proven concomitant influenza.
T365 6246-6499 Sentence denotes Other antiviral agents currently being investigated in RCT for the treatment of COVID-19 patients are favipiravir, an RNA-dependent RNA polymerase inhibitor with anti-influenza activity, and umifenovir, and anti-influenza membrane fusion inhibitor [29].
T366 6500-6862 Sentence denotes Even though these two agents attracted important media attention in the last few months, and even though there were some favourable preliminary results, especially for favipiravir, released as preprints, we advocate caution in using these agents outside investigational studies until completion of the standard peer-review processes of the first released trials.
T367 6863-7328 Sentence denotes For example, in a recent RCT comparing 120 COVID-19 patients treated with favipiravir versus 120 COVID-19 patients receiving umifenovir, higher rates of clinical recovery were observed in patients receiving favipiravir, but it is of note that the all-cause mortality was 0 in the entire study population, making it uncertain whether, if confirmed, these favourable results may be extrapolated to relevant survival endpoints in critically ill COVID-19 patients [30].
T368 7329-7469 Sentence denotes Finally, antiviral activity against SARS-CoV-2 in vitro has been recently reported for ivermectin, but clinical data are still lacking [31].
T369 7471-7491 Sentence denotes Question 2 statement
T370 7492-7622 Sentence denotes At the present time, evidence from the first published RCT does not support off-label treatment with LPV/RTV in COVID-19 patients.
T371 7623-7767 Sentence denotes This result should also discourage the use of other protease inhibitors (e.g. darunavir), at least until results of dedicated RCT are available.
T372 7768-8000 Sentence denotes Although promising in preclinical studies, remdesivir should be currently provided for treating COVID-19 patients only within RCT (preferentially) or compassionate-use/expanded-access programmes, owing to its investigational nature.
T373 8001-8182 Sentence denotes Pending high-level supporting evidence, favipiravir and umifenovir should not be provided outside RCT, at least in those countries where they are not approved for other indications.
T374 8183-8290 Sentence denotes Oseltamivir or zanamivir should be provided only in the presence of suspected/proven concomitant influenza.

2_test

Id Subject Object Predicate Lexical cue
32360444-27585965-22369760 625-627 27585965 denotes 19
32360444-27344959-22369761 631-633 27344959 denotes 20
32360444-26198719-22369762 637-639 26198719 denotes 21
32360444-32187464-22369763 781-783 32187464 denotes 22
32360444-32020029-22369764 5238-5240 32020029 denotes 23
32360444-31924756-22369765 5244-5246 31924756 denotes 24
32360444-32054787-22369766 5250-5252 32054787 denotes 25
32360444-15200845-22369767 5875-5877 15200845 denotes 27
32360444-32007143-22369768 6063-6065 32007143 denotes 28
32360444-32147628-22369769 6495-6497 32147628 denotes 29
32360444-32251768-22369770 7465-7467 32251768 denotes 31